The Midlands Rare Disease Showcase
https://www.eventbrite.co.uk/e/midlands-rare-disease-showcase-tickets-25676373725
Newsletters and Deep Dive digital magazine
https://www.eventbrite.co.uk/e/midlands-rare-disease-showcase-tickets-25676373725
A new programme announced by the FDA will work towards the use of augmented reality and virtual reality (AR/VR) to make patients’ own homes an integral part of the healthc
AstraZeneca’s Ultomiris has been approved by the FDA to treat rare autoimmune disease neuromyelitis optica spectrum disorder (NMOSD), six months after an earlier applicati
Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.
Over the last five years, a confluence of trends have combined to reshape the reality of clinical research. COVID-19 pushed decentralised trials into the mainstream.
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
The 5th Optimizing Hybrid Clinical Trials Summit (September 11-12, 2024 | Boston, MA) is uniting stakeholders in Clinical Operations, Innovation, Procurement and Digital Health and
The PM Society is a not-for-profit organisation with 40 years of Giving Back.
Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox